Systemic lupus erythematosus with sjögren syndrome compared to systemic lupus erythematosus alone: A meta-analysis

Journal of Clinical Rheumatology

Volumn 18, Issue 1, 2012, Pages 28-32

  Yao, Qingping ^a   Altman, Roy D ^b   Wang, Xiaofeng ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antiYdouble stranded DNA antibodies; meta analysis; Sj gren syndrome; systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY;

ABNORMAL LABORATORY RESULT; ARTHRITIS; CLINICAL FEATURE; FACE RASH; HEMATURIA; HEMOLYTIC ANEMIA; HUMAN; INFLAMMATION; LEUKOPENIA; MOUTH ULCER; MYOSITIS; NEPHRITIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEINURIA; RAYNAUD PHENOMENON; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84855207957     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31823ecbdf     Document Type: Review

References (25)

1. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren's syndrome. Nat Clin Pract Rheumatol. 2006;2:252-261.
2. Steinberg AD, Talal N. The coexistence of Sjögren's syndrome and systemic lupus erythematosus. Ann Intern Med. 1971;74:55-61.
3. Alarcon-Segovia D, Ibanez G, Velazquez-Forero F, et al. Sjögren's syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations. Ann Intern Med. 1974;81:577-583.
4. Nossent JC, Swaak AJ. Systemic lupus erythematosus VII: Frequency and impact of secondary Sjögren's syndrome. Lupus. 1998;7:231-234. (Pubitemid 28264000)
5. Manoussakis MN, Georgopoulou C, Zintzaras E, et al. Sjögren's syndrome associated with systemic lupus erythematosus: Clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum. 2004;50:882-891. (Pubitemid 38326189)
6. Szanto A, Szodoray P, Kiss E, et al. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus. Hum Immunol. 2006;67:924-930. (Pubitemid 44834549)
7. Pan HF, Ye DQ, Wang Q, et al. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: A study of 542 patients. Clin Rheumatol. 2008;27:339-343.
8. Xu D, Tian X, Zhang W, et al. Sjögren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: A case-control study. Lupus. 2010;19:197-200.
9. Baer AN, Maynard JW, Shaikh F, et al. Secondary Sjögren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010;37:1143-1149.
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558. (Pubitemid 34746062)
11. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
12. Andonopoulos AP, Skopouli FN, Dimou GS, et al. Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol. 1990;17:201-204. (Pubitemid 20108223)
13. Hamilton RG, Harley JB, Bias WB, et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum. 1988;31:496-505.
14. Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest. 1982;69:835-843. (Pubitemid 12149161)
15. Malik S, Bruner GR, Williams-Weese C, et al. Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients. Lupus. 2007;16:863-866. (Pubitemid 350157271)
16. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 2005;52:4003-4010. (Pubitemid 41798240)
17. Meilof JF, Veldhoven CH, Swaak AJ, et al. Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production. J Autoimmun. 1997;10:67-75. (Pubitemid 27110309)
18. Zhang W, Reichlin M. Some autoantibodies to Ro/SS-A and La/SS-B are antiidiotypes to antiYdouble-stranded DNA. Arthritis Rheum. 1996;39:522-531.
19. Onishi S, Nagashima T, Kimura H, et al. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon → used for the treatment of hepatitis C. Lupus. 2010;19:753-755.
20. Padalko EY, Bossuyt X. Anti-dsDNA antibodies associated with acute EBV infection in Sjögren's syndrome. Ann Rheum Dis. 2001;60:992. (Pubitemid 32885686)
21. Scofield RH. Genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol. 2009;21:448-453.
22. Korman BD, Alba MI, Le JM, et al. Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun. 2008;9:267-270. (Pubitemid 351584194)
23. Nordmark G, Kristjansdottir G, Theander E, et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun. 2009;10:68-76.
24. Gottenberg JE, Busson M, Loiseau P, et al. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 2003;48:2240-2245. (Pubitemid 36959205)
25. Skopouli FN, Dafni U, Ioannidis JP, et al. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum. 2000;29:296-304. (Pubitemid 30235981)